23.06新台幣0.03(0.13%)
2023/12/07更新
績效 / 1月1.58%
3月3.56%
1年2.25%
晨星評等 - 1.現金2.46%
- 2.股票25.34%
- 3.債券0.00%
- 4.其他72.20%
- 1.美國72.69%
- 2.歐洲不包含歐元區13.16%
- 3.英國6.32%
- 4.日本5.01%
- 5.歐元區0.85%
- 1.Eli Lilly and Co9.74%
- 2.Regeneron Pharmaceuticals Inc9.51%
- 3.Novo Nordisk A/S Class B8.82%
- 4.Vertex Pharmaceuticals Inc6.59%
- 5.AstraZeneca PLC6.32%
- 6.Gilead Sciences Inc6.02%
- 7.Neurocrine Biosciences Inc4.05%
- 8.Amgen Inc3.58%
- 9.Biomarin Pharmaceutical Inc3.26%
- 10.Genmab A/S3.24%
- 1.現金2.46%
- 2.股票25.34%
- 3.債券0.00%
- 4.其他72.20%
- 1.美國72.69%
- 2.歐洲不包含歐元區13.16%
- 3.英國6.32%
- 4.日本5.01%
- 5.歐元區0.85%
- 1.Eli Lilly and Co9.74%
- 2.Regeneron Pharmaceuticals Inc9.51%
- 3.Novo Nordisk A/S Class B8.82%
- 4.Vertex Pharmaceuticals Inc6.59%
- 5.AstraZeneca PLC6.32%
- 6.Gilead Sciences Inc6.02%
- 7.Neurocrine Biosciences Inc4.05%
- 8.Amgen Inc3.58%
- 9.Biomarin Pharmaceutical Inc3.26%
- 10.Genmab A/S3.24%